Skip to content

Nevirapine safe and effective in patients with a CD4 cell count below 200

Importance of biopsies for confirming cause of muscle disease in HIV patients shown by case reports

Acetyl-l-carnitine can improve peripheral neuropathy, study shows

First treatment for facial fat loss approved in US

Report of rare atazanavir-related liver side-effect published

Fluconazole doubles nevirapine levels, greatly increasing risk of liver toxicity

Nevirapine liver toxicity associated with CD4 percentage over 25% and genetic factors, rash alone with genetic factors only

Cumulative time on HAART increases health risks to both mother and foetus

Low risk of serious kidney toxicity on tenofovir, but mild renal dysfunction cause for concern